Botulinum Toxin Market (By Product: Botulinum Toxin Type B, Botulinum Toxin Type A; By End Use: Therapeutics, Aesthetic) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

According to Acumen Research and Consulting, the global Botulinum Toxin market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 7.5 billion by 2026.

The imperative quality needs and fresh apps are sustaining competition in the worldwide industry of botulinum toxins. Most businesses invest in studies to identify fresh apps which can assist them achieve a higher share and benefit from the worldwide market for botulinum toxins. In addition, the need for high quality requires businesses to implement quality control methods in view of present product apps.

The report provides analysis of global Botulinum Toxin market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

Market Dynamics

Creating a growing population between the ages of 25 and 65 and growing demand for minimally invasive or non-invasive processes are key drivers of world market growth.

BNT is a neurotoxin that is generated in the anaerobic plant, Clostridium Botulinum, with seven distinct types of antigens, namely BNT- a, B, C, D, E, F and G. For esthetic applications, BNT is used extensively. Currently there are commercially available a few BNT-A and just one BNT-B products on the market. However, heavy research & development investments to develop botulinum toxin therapeutic use create possibilities in the near future to expand its scope of use.

Neurotoxins, in addition to cosmetic applications, are hindered by side effects such as allergic reactions, rash, neck and back pain, trouble swallowing, short-sightedness and nausea. Furthermore, high costs for the performance of such costly processes and bad reimbursement coverage by Solstice Neurosciences, LLC for products such as Myobloc further hinder the development of the industry.

Product Outlook

With the biggest share in 2015, the BNTA segment is leading the worldwide market. During the forecast period, this segment is to continue to dominate. Diverse BNTA goods, including major brands such as Botox and Dysport, are commercially accessible on the market. Botox has esthetic implementation in the removal and therapeutic treatments of serious axillary main hyperidrosis and blepharospasm and cervical dystonia, with mild and severe glabelar lines. Xeomin is also used in certain nations to remove glabellar lines and treat cervical dystonia and blepharospasm. However, there are few side effects, including allergic responses, nausea, rash, neck and back pain, that have been noted. Products from BNTA also cost a great deal and cost a lot during operations. Therefore, these variables hamper market growth.

Application Stance

Toxin botulinum is used mainly to enhance facial appearance and to reduce signs of aging in cosmetic (esthetic) applications. The frown lines, crow's foot and glabellar lines are to be treated. This led to a greater market share of the esthetic segment in 2015.

Allergan got the U.S. botulinum toxin (Botox) Approval of FDA in 2004 for hyperhidrosis, cervical dystonia in 2009, post-strokes spasticity for the upper limb in 2010 and overactive bladder and urinary incontinence in 2011. It is thus noted that the Botox use is expanded through multiple signs through consistent R&D attempts.

Furthermore, other products, such as dysport and xeomin, are used to treat blepharospasm and hyperidrose. Myobloc is also used for the treatment of cervical dystonia, a botulinum toxin B (BNTB), which is commercially accessible under the brand name. Given the ever increasing use of botulinum toxin in therapeutic apps, therapeutic applications are expected to increase considerably during the predicted period.

Therapeutic applications of botulinum toxin in cosmetic apps that pave the way for additional development in the application field

While botulinum toxin is believed to be used mainly for the treatment of cosmetic diseases, the therapeutic application is far more than cosmetic. For chronic migraine, muscle spast, reagent bladder, and hyperhidrosis cases, botulinum toxin is an efficient therapy alternative. In addition, in females with endometriosis, botulinum toxin has been discovered to be highly efficient in alleviating chronic instances of pelvic pain. Studies show that botulinum toxin injected patients have been able to remain free for up to 11 months. In cosmetic applications such as forehead lines, crown feet, square jaw / masseter brown lines / bellar, and others, botulinum toxin is also commonly used. botulinum toxin is also used. The therapeutic industry, however, is anticipated to grow rapidly and the demand for botulinum toxin in muscle spasm treatment in the coming years is projected to increase exponentially.

Botulinum toxin has been shown to treat invasive diseases like fasciitis

Fasciitis necrotizing is an uncommon type of fatal illness that is consumed in human beings and may harm human life if not properly diagnosed and handled instantly. This skin disease spreads rapidly across the body because of a number of bacterial strains and diminishes the capacity of the body to efficiently combat infection. New studies have shown that the administration of botulinum toxin to Necrotized Fasciitis patients helps to block nerve signals and control the infection's spread. In the course of fresh research and innovation studies, the role of botulinum toxin in treatment of chronic diseases is expected to increase market growth.

Regional Stance

By gaining the biggest share of sales in 2015, North America dominated the market. The demand for botulinum toxin in North America has increased disposable revenues and a range of esthetic processes for increasing external appearance.

Asia Pacific is anticipated to grow most soon as demographics and disposable income grow older and the demand for anti-aging products rises. Moreover, a increasing social awareness of the market accessibility of these goods in Asia Pacific is expected to increase market development in the near future.

Market Segmentation

Global Botulinum Toxin Market, By Product

  • Botulinum Toxin Type B
  • Botulinum Toxin Type A

Global Botulinum Toxin Market, By End Use

  • Therapeutics
  • Aesthetic

Global Botulinum Toxin Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Botulinum Toxin Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Botulinum Toxin market segments with market dynamics and their impact. The report also covers basic technology development policies.

The report provides an analysis of the latest trends and opportunities in each of the sub-segment from 2015 to 2026 and forecasts revenue growth in the global, regional and country levels. ARC has divided the botulinum toxin market by product, end usage and region for this research.

Our reports are one-point solutions for the growth, development and maturity of companies. Our information collection techniques in real time, together with the capacity to track over a million high-growth niche products, meet your goals. In order for our analysts to make correct decisions, the detailed and proprietary statistical models are used in the shortest period of time. We deliver tailored alternatives through ad-hoc reports for organisations that need particular but thorough data. These applications have the perfect combination of the correct sense of fact-oriented methodologies for issue solving and leveraging current repositories.

Key Players & Strategies

The main business players are The Ipsen Group ; Allergan, Inc.; Merz Pharma GmbH and Co. These businesses have a powerful world market position, primarily owing to their powerful brand image and accessibility worldwide.

Other market players include US Worldmed, LLC; Medytox, Inc.; Lanzhou Biological Products Institute Co. Ltd., and Therapeutics Revance, Inc. The market competition is anticipated to increase in the near future as various businesses now concentrate on their study efforts to introduce new therapeutic applications of the current products.

Related Reports

Behavioral Health Market (By Disorder: Alcohol Use Disorders, Schizophrenia, Bipolar Disorder, Depression, Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, Others; By Service: Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,

Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu

Sacral Nerve Stimulation Market (By Product: Implantable, External; By Application: Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro

Medical Imaging Workstations Market (By Modality: Computed Tomography, MRI, X-ray; By Component: Visualization Software, Display Units; By Usage Mode: Thin, Thick; By Application: Diagnostic Imaging, Clinical Review; By End User: Hospital and Clinics, Diagnostics Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased

Laser Hair Removal Market (End User: Dermatology Clinics, Beauty Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo

Idiopathic Pulmonary Fibrosis Treatment Market (By Drug Class: Tyrosine Inhibitors, MAPK Inhibitors, Autotaxin Inhibitors; By End User: Hospitals, Long-term Care Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t

Cart Summary